Trial Profile
Stereotactic accelerated radiotherapy concurrent with Temozolomide chemotherapy in newly diagnosed glioblastoma
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2012
Price :
$35
*
At a glance
- Drugs Temozolomide (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- 08 Jun 2011 New trial record